The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Research Report 2024
Synopsis
Pacemaker is a medical device that uses electric shocks to continuously and regularly stimulate the heart muscles to maintain the continuous beating of the heart. Implantable cardioverter defibrillators or automatic implantable cardioverter defibrillators are devices that can be implanted in the body and can perform cardioversion, defibrillation and pacing of the heart. Therefore, the device can correct most life-threatening arrhythmias. For patients at risk of sudden cardiac death due to ventricular fibrillation and ventricular tachycardia, ICD is the first-line treatment and preventive treatment.
The global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
This report focuses on Pacemakers and Implantable Cardioverter Defibrillators (ICDs) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Pacemakers and Implantable Cardioverter Defibrillators (ICDs) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Pacemakers
Implantable Cardioverter Defibrillators
Segment by Application
Hospitals
Speciality Clinics & Cardiac Centres
Ambulatory centres
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Medtronic Inc.
Boston Scientific
ZOLL Medical Corp.
Asahi Kasei Corp.
Nihon Kohden Corp.
Shree Pacetronix Ltd.
St. Jude Medical, Inc
BIOTRONIK SE & Co. KG
EBR Systems, Inc.
MEDICO S.p.A.
Osypka Medical GmbH
Physio-Control Corp.
Pacemaker is a medical device that uses electric shocks to continuously and regularly stimulate the heart muscles to maintain the continuous beating of the heart. Implantable cardioverter defibrillators or automatic implantable cardioverter defibrillators are devices that can be implanted in the body and can perform cardioversion, defibrillation and pacing of the heart. Therefore, the device can correct most life-threatening arrhythmias. For patients at risk of sudden cardiac death due to ventricular fibrillation and ventricular tachycardia, ICD is the first-line treatment and preventive treatment.
The global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
This report focuses on Pacemakers and Implantable Cardioverter Defibrillators (ICDs) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Pacemakers and Implantable Cardioverter Defibrillators (ICDs) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Pacemakers
Implantable Cardioverter Defibrillators
Segment by Application
Hospitals
Speciality Clinics & Cardiac Centres
Ambulatory centres
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Medtronic Inc.
Boston Scientific
ZOLL Medical Corp.
Asahi Kasei Corp.
Nihon Kohden Corp.
Shree Pacetronix Ltd.
St. Jude Medical, Inc
BIOTRONIK SE & Co. KG
EBR Systems, Inc.
MEDICO S.p.A.
Osypka Medical GmbH
Physio-Control Corp.
Index1 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Overview
1.1 Product Overview and Scope of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)
1.2 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Segment by Type
1.2.1 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Pacemakers
1.2.3 Implantable Cardioverter Defibrillators
1.3 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Segment by Application
1.3.1 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Speciality Clinics & Cardiac Centres
1.3.4 Ambulatory centres
1.3.5 Others
1.4 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Size Estimates and Forecasts
1.4.1 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue 2016-2027
1.4.2 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales 2016-2027
1.4.3 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Size by Region: 2016 Versus 2021 Versus 2027
2 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Competition by Manufacturers
2.1 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Manufacturers (2016-2021)
2.2 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Manufacturing Sites, Area Served, Product Type
2.5 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Competitive Situation and Trends
2.5.1 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Players Market Share by Revenue
2.5.3 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Retrospective Market Scenario by Region
3.1 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Facts & Figures by Country
3.3.1 North America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Country
3.3.2 North America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Facts & Figures by Country
3.4.1 Europe Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Country
3.4.2 Europe Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Facts & Figures by Region
3.5.1 Asia Pacific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Region
3.5.2 Asia Pacific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Facts & Figures by Country
3.6.1 Latin America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Country
3.6.2 Latin America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Facts & Figures by Country
3.7.1 Middle East and Africa Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Country
3.7.2 Middle East and Africa Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Historic Market Analysis by Type
4.1 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Type (2016-2021)
4.2 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Market Share by Type (2016-2021)
4.3 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Price by Type (2016-2021)
5 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Historic Market Analysis by Application
5.1 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Application (2016-2021)
5.2 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Market Share by Application (2016-2021)
5.3 Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Medtronic Inc.
6.1.1 Medtronic Inc. Corporation Information
6.1.2 Medtronic Inc. Description and Business Overview
6.1.3 Medtronic Inc. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Medtronic Inc. Product Portfolio
6.1.5 Medtronic Inc. Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Corporation Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Boston Scientific Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 ZOLL Medical Corp.
6.3.1 ZOLL Medical Corp. Corporation Information
6.3.2 ZOLL Medical Corp. Description and Business Overview
6.3.3 ZOLL Medical Corp. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales, Revenue and Gross Margin (2016-2021)
6.3.4 ZOLL Medical Corp. Product Portfolio
6.3.5 ZOLL Medical Corp. Recent Developments/Updates
6.4 Asahi Kasei Corp.
6.4.1 Asahi Kasei Corp. Corporation Information
6.4.2 Asahi Kasei Corp. Description and Business Overview
6.4.3 Asahi Kasei Corp. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Asahi Kasei Corp. Product Portfolio
6.4.5 Asahi Kasei Corp. Recent Developments/Updates
6.5 Nihon Kohden Corp.
6.5.1 Nihon Kohden Corp. Corporation Information
6.5.2 Nihon Kohden Corp. Description and Business Overview
6.5.3 Nihon Kohden Corp. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Nihon Kohden Corp. Product Portfolio
6.5.5 Nihon Kohden Corp. Recent Developments/Updates
6.6 Shree Pacetronix Ltd.
6.6.1 Shree Pacetronix Ltd. Corporation Information
6.6.2 Shree Pacetronix Ltd. Description and Business Overview
6.6.3 Shree Pacetronix Ltd. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Shree Pacetronix Ltd. Product Portfolio
6.6.5 Shree Pacetronix Ltd. Recent Developments/Updates
6.7 St. Jude Medical, Inc
6.6.1 St. Jude Medical, Inc Corporation Information
6.6.2 St. Jude Medical, Inc Description and Business Overview
6.6.3 St. Jude Medical, Inc Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 St. Jude Medical, Inc Product Portfolio
6.7.5 St. Jude Medical, Inc Recent Developments/Updates
6.8 BIOTRONIK SE & Co. KG
6.8.1 BIOTRONIK SE & Co. KG Corporation Information
6.8.2 BIOTRONIK SE & Co. KG Description and Business Overview
6.8.3 BIOTRONIK SE & Co. KG Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales, Revenue and Gross Margin (2016-2021)
6.8.4 BIOTRONIK SE & Co. KG Product Portfolio
6.8.5 BIOTRONIK SE & Co. KG Recent Developments/Updates
6.9 EBR Systems, Inc.
6.9.1 EBR Systems, Inc. Corporation Information
6.9.2 EBR Systems, Inc. Description and Business Overview
6.9.3 EBR Systems, Inc. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales, Revenue and Gross Margin (2016-2021)
6.9.4 EBR Systems, Inc. Product Portfolio
6.9.5 EBR Systems, Inc. Recent Developments/Updates
6.10 MEDICO S.p.A.
6.10.1 MEDICO S.p.A. Corporation Information
6.10.2 MEDICO S.p.A. Description and Business Overview
6.10.3 MEDICO S.p.A. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales, Revenue and Gross Margin (2016-2021)
6.10.4 MEDICO S.p.A. Product Portfolio
6.10.5 MEDICO S.p.A. Recent Developments/Updates
6.11 Osypka Medical GmbH
6.11.1 Osypka Medical GmbH Corporation Information
6.11.2 Osypka Medical GmbH Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Description and Business Overview
6.11.3 Osypka Medical GmbH Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Osypka Medical GmbH Product Portfolio
6.11.5 Osypka Medical GmbH Recent Developments/Updates
6.12 Physio-Control Corp.
6.12.1 Physio-Control Corp. Corporation Information
6.12.2 Physio-Control Corp. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Description and Business Overview
6.12.3 Physio-Control Corp. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Physio-Control Corp. Product Portfolio
6.12.5 Physio-Control Corp. Recent Developments/Updates
7 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Manufacturing Cost Analysis
7.1 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)
7.4 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Distributors List
8.3 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Customers
9 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Dynamics
9.1 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Industry Trends
9.2 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Growth Drivers
9.3 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Challenges
9.4 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Restraints
10 Global Market Forecast
10.1 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) by Type (2022-2027)
10.2 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) by Application (2022-2027)
10.3 Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Covered in This Study
Table 5. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Share by Manufacturers (2016-2021)
Table 7. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Manufacturing Sites and Area Served
Table 11. Manufacturers Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product Type
Table 12. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pacemakers and Implantable Cardioverter Defibrillators (ICDs) as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Region (2016-2021) & (K Units)
Table 16. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Region (2016-2021)
Table 17. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Country (2016-2021) & (K Units)
Table 19. North America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Country (2016-2021)
Table 20. North America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Market Share by Country (2016-2021)
Table 22. Europe Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Country (2016-2021) & (K Units)
Table 23. Europe Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Country (2016-2021)
Table 24. Europe Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Market Share by Region (2016-2021)
Table 30. Latin America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Country (2016-2021)
Table 32. Latin America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Market Share by Country (2016-2021)
Table 38. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales (K Units) by Type (2016-2021)
Table 39. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Type (2016-2021)
Table 40. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue (Million US$) by Type (2016-2021)
Table 41. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Share by Type (2016-2021)
Table 42. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Price (US$/Unit) by Type (2016-2021)
Table 43. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales (K Units) by Application (2016-2021)
Table 44. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Application (2016-2021)
Table 45. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue (Million US$) by Application (2016-2021)
Table 46. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Share by Application (2016-2021)
Table 47. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Price (US$/Unit) by Application (2016-2021)
Table 48. Medtronic Inc. Corporation Information
Table 49. Medtronic Inc. Description and Business Overview
Table 50. Medtronic Inc. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Medtronic Inc. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product
Table 52. Medtronic Inc. Recent Developments/Updates
Table 53. Boston Scientific Corporation Information
Table 54. Boston Scientific Description and Business Overview
Table 55. Boston Scientific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Boston Scientific Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product
Table 57. Boston Scientific Recent Developments/Updates
Table 58. ZOLL Medical Corp. Corporation Information
Table 59. ZOLL Medical Corp. Description and Business Overview
Table 60. ZOLL Medical Corp. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. ZOLL Medical Corp. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product
Table 62. ZOLL Medical Corp. Recent Developments/Updates
Table 63. Asahi Kasei Corp. Corporation Information
Table 64. Asahi Kasei Corp. Description and Business Overview
Table 65. Asahi Kasei Corp. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Asahi Kasei Corp. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product
Table 67. Asahi Kasei Corp. Recent Developments/Updates
Table 68. Nihon Kohden Corp. Corporation Information
Table 69. Nihon Kohden Corp. Description and Business Overview
Table 70. Nihon Kohden Corp. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Nihon Kohden Corp. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product
Table 72. Nihon Kohden Corp. Recent Developments/Updates
Table 73. Shree Pacetronix Ltd. Corporation Information
Table 74. Shree Pacetronix Ltd. Description and Business Overview
Table 75. Shree Pacetronix Ltd. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Shree Pacetronix Ltd. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product
Table 77. Shree Pacetronix Ltd. Recent Developments/Updates
Table 78. St. Jude Medical, Inc Corporation Information
Table 79. St. Jude Medical, Inc Description and Business Overview
Table 80. St. Jude Medical, Inc Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. St. Jude Medical, Inc Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product
Table 82. St. Jude Medical, Inc Recent Developments/Updates
Table 83. BIOTRONIK SE & Co. KG Corporation Information
Table 84. BIOTRONIK SE & Co. KG Description and Business Overview
Table 85. BIOTRONIK SE & Co. KG Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. BIOTRONIK SE & Co. KG Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product
Table 87. BIOTRONIK SE & Co. KG Recent Developments/Updates
Table 88. EBR Systems, Inc. Corporation Information
Table 89. EBR Systems, Inc. Description and Business Overview
Table 90. EBR Systems, Inc. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. EBR Systems, Inc. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product
Table 92. EBR Systems, Inc. Recent Developments/Updates
Table 93. MEDICO S.p.A. Corporation Information
Table 94. MEDICO S.p.A. Description and Business Overview
Table 95. MEDICO S.p.A. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. MEDICO S.p.A. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product
Table 97. MEDICO S.p.A. Recent Developments/Updates
Table 98. Osypka Medical GmbH Corporation Information
Table 99. Osypka Medical GmbH Description and Business Overview
Table 100. Osypka Medical GmbH Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Osypka Medical GmbH Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product
Table 102. Osypka Medical GmbH Recent Developments/Updates
Table 103. Physio-Control Corp. Corporation Information
Table 104. Physio-Control Corp. Description and Business Overview
Table 105. Physio-Control Corp. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Physio-Control Corp. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Product
Table 107. Physio-Control Corp. Recent Developments/Updates
Table 108. Production Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Distributors List
Table 111. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Customers List
Table 112. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Trends
Table 113. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Growth Drivers
Table 114. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Restraints
Table 115. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Forecast by Type (2022-2027) & (K Units)
Table 116. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share Forecast by Type (2022-2027)
Table 117. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 118. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Market Share Forecast by Type (2022-2027)
Table 119. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Forecast by Application (2022-2027) & (K Units)
Table 120. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share Forecast by Application (2022-2027)
Table 121. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 122. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Market Share Forecast by Application (2022-2027)
Table 123. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Forecast by Region (2022-2027) & (K Units)
Table 124. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share Forecast by Region (2022-2027)
Table 125. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 126. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Market Share Forecast by Region (2022-2027)
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)
Figure 2. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Share by Type in 2020 & 2027
Figure 3. Pacemakers Product Picture
Figure 4. Implantable Cardioverter Defibrillators Product Picture
Figure 5. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Share by Application in 2020 & 2027
Figure 6. Hospitals
Figure 7. Speciality Clinics & Cardiac Centres
Figure 8. Ambulatory centres
Figure 9. Others
Figure 10. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Size 2016-2027 (US$ Million)
Figure 12. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales 2016-2027 (K Units)
Figure 13. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Share by Manufacturers in 2020
Figure 15. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Players: Market Share by Revenue in 2020
Figure 17. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Region (2016-2021)
Figure 19. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Sales Market Share by Region in 2020
Figure 20. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Market Share by Region (2016-2021)
Figure 21. Global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Market Share by Region in 2020
Figure 22. U.S. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. UAE Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) by Type (2016-2021)
Figure 47. Sales Market Share of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) by Application (2016-2021)
Figure 48. Sales Market Share of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) by Application in 2020
Figure 49. Revenue Share of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) by Application (2016-2021)
Figure 50. Revenue Share of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) by Application in 2020
Figure 51. Manufacturing Cost Structure of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)
Figure 52. Manufacturing Process Analysis of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)
Figure 53. Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
